MOLLY RECKTENWALD: Open Payments
NPI 1639834187 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,440 in 36 payments from 12 companies in 2025. Trend: 2023 $762 · 2024 $1,399 · 2025 $1,440
Food & beverage: $1,440
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $743 |
| Vanda Pharmaceuticals Inc. | 7 | $283 |
| ABBVIE INC. | 6 | $106 |
| Exact Sciences Corporation | 5 | $82 |
| Dynavax Technologies Corporation | 4 | $65 |
| Axsome Therapeutics, Inc. | 2 | $54 |
| Medtronic, Inc. | 1 | $24 |
| Ardelyx, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Novo Nordisk Inc | 1 | $16 |
Products named: BREZTRI, PONVORY, AIRSUPRA, HETLIOZ, FARXIGA, VRAYLAR, Cologuard Collection Kit, Heplisav-B.
Industry payments across KY — which companies pay providers there.
